N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine(CAS: 904326-88-1)

N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine is subject to regulatory guidelines under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous substances. It must comply with the European Union's Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulations. Additionally, it falls under the jurisdiction of the U.S. Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) for any pharmaceutical or environmental applications.

Several alternatives can be used in the synthesis of N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, such as other boronic acids or esters. Commonly, researchers use 4,4,5,5-tetramethyl-2-borabicyclo[4.3.0]non-2-ene or other related compounds as more readily available or cost-effective substitutes.

N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine is increasingly being explored in pharmaceutical research for its potential as a drug candidate. Market trends indicate growing interest in its use as an intermediate in organic synthesis and as a building block for more complex molecules. Recent studies focus on its biological activity and synthetic versatility.

Waste containing N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine should be collected in suitable containers and disposed of through a licensed hazardous waste disposal service. Proper incineration or reclamation processes are recommended, following local environmental protection regulations. Precautions include ensuring the waste is labeled correctly and stored in a secure, ventilated area to prevent contamination or exposure.